Cancer BiologybioRxiv
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
D. Hany, M. Zoetemelk, K. Bhattacharya…·D. Picard
The paper identifies effective low-dose multidrug combinations for ER+/HER2-/PI3Kα-mutant breast cancer using network analysis and experimental validation.
DOI 10.1007/s00018-023-04730-x